Connect Biopharma Holdings Limited Insider Share Purchases


2025-09-16SEC Filing 8-K (0001835268-25-000056)

Connect Biopharma Holdings Limited reported that its CEO, Barry D. Quart, purchased 224,034 shares of the company between September 2024 and September 2025. Additionally, the company's President, David Szekeres, purchased 215,739 shares between November 2024 and September 2025. These transactions were conducted in compliance with the company's Insider Trading Compliance Policy. The information provided in this Form 8-K is intended to be furnished and shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.


Tickers mentioned in this filing:CNTB